CLINICAL TRIAL

Feb 04 2025HEALTH

Metformin: A Potential Guardian Against Steroid Side Effects

Imagine you are tackling an illness that requires you to take steroids. These steroids are strong fighters against inflammation, but they can also cause problems. Metformin, a well-known diabetes medication, might just be the superhero we need to protect us from these side effects. Typically, it is

reading time less than a minute
Feb 03 2025HEALTH

Which Drug Works Best for Lungs Affected by Scleroderma?

Let's talk about a tough condition called Scleroderma, specifically the kind that affects the lungs. People with this trouble often get medicines to try and control it. To find out which drugs work best, researchers looked at four commonly used medicines: tocilizumab, rituximab, mycophenolate mofeti

reading time less than a minute
Feb 03 2025SCIENCE

Blazing a Trail in Vision Treatment

Diving right in, choroideremia is a rare disease that affects a person's vision and is a big deal for patients. It's like a storm in a small town. This gene-related condition can severely impact a person's quality of life. Gene therapy, a fancy word for fixing genetic issues, has been a big

reading time less than a minute
Feb 02 2025HEALTH

Can Lifestyle Changes Help Alzheimer’s Disease?

The effect of major lifestyle changes on mild cognitive impairment or early dementia due to Alzheimer's disease is no small matter. It is really important to actually prove that lifestyle changes work for Alzheimer’s. Rigorous clinical trials are needed to test whether lifestyle interventions can

reading time less than a minute
Feb 02 2025HEALTH

Medical Milestone: Finding New Hope for Advanced Colon Cancer

The need to find new treatment options for patients with advanced colon cancer has always been a challenge for doctors. The medical community has been using a combination of FOLFOXIRI and bevacizumab as a first line treatment. This is a potent cocktail of chemotherapy drugs that fight cancer cells i

reading time less than a minute
Feb 01 2025HEALTH

CAPVAXIVE SUFFERS BIBLING PLEAS. WILLUSERS AND THE PROJECT TALK ALL THE BUNG

Remember those pesky pneumococcal outbreaks Only here apparently. Streptococcus pneumoniae. Differentiating much like first appearing in adults, Then children. These germs have some 90 odd serotypes, each having pretty much universality in majorities of problematic infections. Especially in adults

reading time less than a minute
Feb 01 2025HEALTH

Ending the Opioid Addictionwith New Journavx Drug

A new painkiller has been approved for sale. This medication, Journavx, is a step forward that skips those addictive opioids that many of us are familiar with. Think of it as a shortcut around the addiction crisis. This pain reliever tackles those intense, short-term pains from things like surgery,

reading time less than a minute
Jan 31 2025HEALTH

Aphasia After Stroke: Can Self-Management Make a Difference?

Aphasia is a tough condition. It makes speaking or understanding language hard. Many people get it after a stroke. Self-management strategies can really help stroke survivors live better. But what about those with aphasia? They often get overlooked in research. So, can self-management help them too

reading time less than a minute
Jan 31 2025HEALTH

What If We Can't Predict Survival Just Yet?

In the realm of randomized clinical trials, researchers have been trying to figure out if certain markers can predict how well a patient with early breast cancer will do in the long run. Early breast cancer is a challenging problem. One of the key challenges is knowing how effective a treatment

reading time less than a minute
Jan 29 2025HEALTH

Less Isn't Always More: Surgery Options for Early-Stage Lung Cancer

You might think that when it comes to early-stage lung cancer, the more you remove, the better. But hold on a minute! Recent studies show that sublobar resection, which removes just a part of the lung, might be just as good as removing the whole lobe. However, if the cancer has invaded the lung's pl

reading time less than a minute